Yann Gricourt

Yann Gricourt

Auto-generated profile, based on publicly available information

Yann Gricourt

Department of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in BJA Open
Verified
Journal Article
Open access
MCMatthieu Clanet
Matthieu Clanet
KTKarim Touihri
Karim Touihri
CHCeline El Haddad
Celine El Haddad
NGNicolas Goldsztejn
Nicolas Goldsztejn
JHJacques Himpens
Jacques Himpens
ADAnne-Catherine Dandrifosse
Anne-Catherine Dandrifosse
The efficacy and safety of opioid-free anaesthesia during bariatric surgery remain debated, particularly when administering multimodal analgesia. As multimodal analgesia has become the standard of care in many centres, we aimed to determine if such a strategy coupled with either dexmedetomidine (opioid-free anaesthesia) or remifentanil with a morphine transition (opioid-based anaesthesia), would reduce postoperative morphine requirements and opioid-related adverse events. In this prospective double-blind study, 172 class III obese patients having laparoscopic gastric bypass surgery were randomly allocated to receive either sevoflurane–dexmedetomidine anaesthesia with a continuous infusion of lidocaine and ketamine (opioid-free group) or sevoflurane–remifentanil anaesthesia with a morphine transition (opioid-based group). Both groups received at anaesthesia induction a bolus of magnesium, lidocaine, ketamine, paracetamol, diclofenac, and dexamethasone. The primary outcome was 24-h postoperative morphine consumption. Secondary outcomes included postoperative quality of recovery (QoR40), incidence of hypoxaemia, bradycardia, and postoperative nausea and vomiting (PONV). Eighty-six patients were recruited in each group (predominantly women, 70% had obstructive sleep apnoea). There was no significant difference in postoperative morphine consumption (median [inter-quartile range]: 16 [13–26] vs 15 [10–24] mg, P=0.183). The QoR40 up to postoperative day 30 did not differ between groups, but PONV was less frequent in the opioid-free group (37% vs 59%, P=0.005). Hypoxaemia and bradycardia were not different between groups. During bariatric surgery, a multimodal opioid-free anaesthesia technique did not decrease postoperative morphine consumption when compared with a multimodal opioid-based strategy. Quality of recovery did not differ between groups although the incidence of PONV was less in the opioid-free group. NCT05004519.

15 October 2025 in BJA Open
Verified
Journal Article
Open access
IEInaame Ettoumi
Inaame Ettoumi
DPDaniel Pearce
Daniel Pearce
TWTheodora Wingert
Theodora Wingert
ADAmelie Delaporte
Amelie Delaporte
BABrenton Alexander
Brenton Alexander
Alexandre JoostenAlexandre Joosten
Alexandre Joosten
Intraoperative hypotension has been associated with postoperative complications, but its relationship with postoperative delirium remains debated. This single-centre retrospective cohort study included adults (≥60 yr) with ASA physical status score of 3 or 4 undergoing major noncardiac surgery, with documented Confusion Assessment Method assessments. Patients with a history of neurosurgery, stroke, dementia, or neurocognitive disorders were excluded. The primary exposure was the cumulative duration of a mean arterial pressure <65 mm Hg (minutes). The primary outcome was postoperative delirium within 7 days, diagnosed via Confusion Assessment Method. Multivariable logistic regression was used to assess the association between intraoperative hypotension and delirium, adjusting for confounders. Among 5171 patients included from 2013–2024, 632 (11.8%) developed delirium. The median (Q1–Q3) duration of surgery and time with mean arterial pressure <65 mm Hg were 281 (199–430) min and 28 (9–61) min, respectively. In models adjusted for patient characteristics and perioperative factors, intraoperative hypotension was associated with increased odds of delirium (odds ratio per 60 min, 1.12; 95% confidence interval, 1.01–1.24; P=0.038). However, after adjusting for year of surgery, the association was attenuated and no longer statistically significant (odds ratio, 1.06; 95% confidence interval, 0.95–1.18; P=0.320). Both intraoperative hypotension exposure and delirium incidence declined significantly over the study period. Although intraoperative hypotension initially appeared to be associated with postoperative delirium, this association was no longer significant when accounting for temporal improvements in perioperative care. Intraoperative hypotension may represent a marker of historical practice patterns rather than an independent causal driver of delirium.

18 June 2025 in BJA Open
Verified
Journal Article
Open access
YGYann Gricourt
Yann Gricourt
NBNancy M. Boulos
Nancy M. Boulos
ADAmelie Delaporte
Amelie Delaporte
BABrenton Alexander
Brenton Alexander
SBStephane Besada
Stephane Besada
Alexandre JoostenAlexandre Joosten
Alexandre Joosten
Although opioids are commonly used to relieve pain associated with surgery, they are not consequence free. Moreover, the USA and many western countries are currently experiencing a significant health crisis because of opioid addiction and its related overdose potential. There have been no studies that have evaluated patient preference regarding opioid use and its potential impact on the quality of recovery. The aim of this study is to compare the effect of patient preference on intraoperative opioid use on early postoperative quality of recovery after moderate risk laparoscopic/robotic abdominal surgery. This trial is an interventional, pragmatic, partially randomised factorial trial. Adults (N=240) scheduled for moderate-risk abdominal surgery under laparoscopic/robotic assistance (colorectal, urologic, and gynaecologic) will be allocated into four groups, according to their preference (choice of opioid-free vs opioid-based anaesthesia vs no choice and, if no choice, then the patient is randomised to opioid-based vs opioid-free anaesthesia). Anaesthesia providers and patients who choose their anaesthesia type will be unblinded of the allocation group. The primary endpoint will be the Quality of Recovery-15 score at postoperative day 1. Secondary endpoints will include patient satisfaction, postoperative nausea and vomiting, intraoperative bradycardia, postoperative opioid consumption, postoperative hypoxemia, and health-related quality of life using the EuroQoL 5-Dimension 5-Level (EQ-5D-5L). This trial will provide evidence on whether patient preference on intraoperative opioid use can improve patient quality of recovery after moderate-risk abdominal surgery. NCT06855641. 2.0, 24 February 2025.

15 December 2025 in BJA Open
Verified
Journal Article
Open access
YGYann Gricourt
Yann Gricourt
NBNancy M. Boulos
Nancy M. Boulos
YDYann Daoulas
Yann Daoulas
TGTristan Grogan
Tristan Grogan
BABrenton Alexander
Brenton Alexander
Alexandre JoostenAlexandre Joosten
Alexandre Joosten
Opioids remain central to perioperative analgesia but concerns about the growing opioid crisis and adverse effects have prompted revaluation of their role. Opioid-sparing anaesthesia and opioid-free anaesthesia (OFA) have emerged as alternatives, yet their clinical adoption remains uncertain. This survey assessed adoption and perceptions among anaesthesiologists in North America and Europe. A 26-question cross-sectional, web-based survey was distributed via email to members of the American, European, and French Societies of anaesthesiologists. The survey assessed routine use of opioid-sparing techniques, defined as the regular use of non-opioid analgesics and adjuncts to minimise intraoperative opioid use in the past month. We hypothesised that fewer than 50% of anaesthesiologists routinely used these techniques during this period. The overall response rate was 2% among ASA members (614/31 000) and 12% among European Society of Anaesthesiology and Intensive Care (ESAIC) members (414/3500). Concern about opioid use was reported as high in ESAIC and ASA members (90% vs 83%, P<0.001). Daily use of opioid sparing techniques was reported by 37% (95% confidence interval [CI] 32–42%) of ESAIC and 40% (95% CI 36–45%) of ASA members. OFA use was less common overall but reported to be higher by ASA repondents (21%, 95% CI 18–25%) vs 12% (95% CI 9–15%), P<0.001) for EASIC respondents. Perceived risks differed: EASIC respondents more often cited haemodynamic instability (43% vs 16%, P<0.001), whereas ASA respondents more often cited patient dissatisfaction (55% vs 30%) and uncontrolled pain (72% vs 53%, both P<0.001). Key barriers to OFA adoption included limited training, low confidence, and lack of evidence-based guidelines. Interest in opioid-sparing anaesthesia and OFA is widespread, but routine use remains modest and varies by region. Regional perceptions, institutional protocols, and confidence in evidence appear to influence implementation.

25 June 2023 in Anesthésie & Réanimation
Verified
Journal Article
Closed access
YGYann Gricourt
Yann Gricourt
PVPierre-Baptiste Vialatte
Pierre-Baptiste Vialatte
GAGeoffrey Avis
Geoffrey Avis
ZAZahir Akkari
Zahir Akkari
PCPhilippe Cuvillon
Philippe Cuvillon

21 November 2022 in Le Praticien en Anesthésie Réanimation
Verified
Journal Article
Closed access
YGYann Gricourt
Yann Gricourt